Scroll to Top

NCDC, PTF Approves Remedesivir For Treatment Of COVID-19; To Partner NAFDAC To Access Drug

The Nigerian Centre for Disease Control (NCDC) and Presidential Task Force (PTF), have both approved Remedesivir as the drug for the treatment of Coronavirus following the likes of the United States and United Kingdom.

The Director-General of NCDC, Dr. Chikwe Ihekweazu, disclosed this on Sunday while  speaking on Channels Television via an @NCDCgov tweet highlights.

Ihekweazu also said that the next step is to work together with NAFDAC to ensure that Nigerians have access to the drugs.

“Since the onset of #COVID19, we committed to follow the science & we’re happy of clinical trial evidence of #remedesivir. Next steps are to work with @NafdacAgency to make the drug accessible.

“We’re part of a global problem & therefore will be part of the solution,” he said.

The NCDC boss further urged Nigerians to be patient and ensure they follow the authorized measures by the Centre, PTF and other relevant bodies, as according to him: “Sometimes speed has its  consequences, however we aree building”.

“Despite best efforts of @PTFCOVID19 & state governments, no response measure to control #COVID19Nigeria will be adequate until Nigerians resolve to adhere to recommended measures”

Ihekweazu also disclosed that in the last one week, they have  trained more lab scientists in Kano to carry out COVID-19 diagnosis at the Aminu Kano Teaching Hospital and Bayero University Kano

He promised to “continue to support the Kano State Government and Kano Stats Ministry of Health @KNSMOH for quick detection of new cases & other response activities”

Like it? Share it!

Leave A Response